Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1...
Saved in:
Published in | Oncogene Vol. 35; no. 24; pp. 3151 - 3162 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
16.06.2016
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3′ untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194.
Spry1
−/−
and
Spry2
−/−
double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. |
---|---|
AbstractList | Abstract
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3′ untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194.
Spry1
−/−
and
Spry2
−/−
double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 52415253). We investigated the mechanisms by which SPRY regulates epithelial mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were signicantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and signicantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3 untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1/ and Spry2/ double mutant mouse embryonic broblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelial-mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1(-/-) and Spry2(-/-) double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3′ untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1 −/− and Spry2 −/− double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelialmesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. [Spry1.sup.-/-] and [Spry2.sup.-/-] double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. Oncogene (2016) 35, 3151-3162;doi: 10.1038/onc.2015.365; published online 5 October 2015 Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelial-mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1 super(-/-) and Spry2 super(-/-) double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelialmesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. [Spry1.sup.-/-] and [Spry2.sup.-/-] double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. |
Audience | Academic |
Author | Wei, T Jurkevich, A Palka-Hamblin, H L Khare, S Zhang, Q Xu, K Shim, K Wright, K |
Author_xml | – sequence: 1 givenname: Q surname: Zhang fullname: Zhang, Q organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri – sequence: 2 givenname: T surname: Wei fullname: Wei, T organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri – sequence: 3 givenname: K surname: Shim fullname: Shim, K organization: Department of Pediatrics, Medical College of Wisconsin – sequence: 4 givenname: K surname: Wright fullname: Wright, K organization: Department of Pediatrics, Medical College of Wisconsin – sequence: 5 givenname: K surname: Xu fullname: Xu, K organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri – sequence: 6 givenname: H L surname: Palka-Hamblin fullname: Palka-Hamblin, H L organization: Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago – sequence: 7 givenname: A surname: Jurkevich fullname: Jurkevich, A organization: Molecular Cytology Core, University of Missouri – sequence: 8 givenname: S surname: Khare fullname: Khare, S email: khares@health.missouri.edu organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri, Harry S. Truman Memorial Veterans’ Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26434583$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksuKFDEUhoOMOD2jO9dS4MaF1eZeKRdCM4wXGHCj65BKTnVnqErKpFrone_gG_okk7bHdkYGJItAznd-Tg7fGToJMQBCzwleEszUmxjskmIilkyKR2hBeCNrIVp-gha4FbhuKaOn6Czna4xx02L6BJ1SyRkXii1QWM27yVszVCkOUMW-ylOK23lX-VDZOMQEdi5Va4KF9PZYTTAlyNnHUMCN7_ycK5j8vIHBm-HXj58jZAh2sxtL85xMyH4u8FP0uDdDhme39zn6-v7yy8XH-urzh08Xq6vaSiLn2vWUgcO0Ex10rjPOdQpEb3nHGShCGFG87U1rFGPCSudE2-BGYmda6VqK2Tl6d8idtt0IzkIoMwx6Sn40aaej8fp-JfiNXsfvmiuBCaEl4NVtQIrftpBnPfpsYRhMgLjNmiisGiI4Zv9Hm7ZRUkolC_ryH_Q6blMom_hN0QZTwv9SazOA9qGPZUS7D9UrLmQjlGCkUMsHqHIcjN4WR3pf3u81vD402BRzTtAf10Gw3quki0p6r5IuKhX8xd0VHuE_7hSgPgDFCR_WkO585qHAG-h_2Bc |
CODEN | ONCNES |
CitedBy_id | crossref_primary_10_3389_fmed_2022_881788 crossref_primary_10_1016_j_prp_2018_09_006 crossref_primary_10_1016_j_yexcr_2019_111644 crossref_primary_10_1002_mgg3_1032 crossref_primary_10_1186_s13058_023_01683_8 crossref_primary_10_1038_s41598_019_39200_7 crossref_primary_10_1002_jcp_29170 crossref_primary_10_1007_s12029_022_00873_5 crossref_primary_10_1007_s13277_016_4790_y crossref_primary_10_1007_s13402_023_00791_z crossref_primary_10_3390_cells8080808 crossref_primary_10_1002_mc_23537 crossref_primary_10_1158_1541_7786_MCR_16_0083 crossref_primary_10_1158_1541_7786_MCR_22_0476 crossref_primary_10_3390_ph15070824 crossref_primary_10_1038_s41419_020_2585_y crossref_primary_10_1016_j_omtn_2019_09_024 crossref_primary_10_3390_cancers12040800 crossref_primary_10_3892_mmr_2019_10852 crossref_primary_10_3390_cells10102632 crossref_primary_10_1186_s12943_017_0737_1 crossref_primary_10_1111_cas_13999 crossref_primary_10_3748_wjg_v25_i31_4468 crossref_primary_10_3892_ol_2018_9433 crossref_primary_10_1016_j_exer_2022_109070 crossref_primary_10_7717_peerj_10824 crossref_primary_10_1007_s00432_023_05314_9 crossref_primary_10_3390_cells11152421 crossref_primary_10_3390_ijms21155353 |
Cites_doi | 10.1016/j.ejca.2011.03.029 10.1038/ncb2976 10.3892/etm.2011.436 10.1073/pnas.0810715105 10.1073/pnas.1302107110 10.1158/0008-5472.CAN-06-1479 10.1016/j.ydbio.2013.04.022 10.1006/dbio.2002.0597 10.7150/thno.8712 10.1038/nature03702 10.1101/gr.2845604 10.3748/wjg.14.3792 10.1210/en.2006-0299 10.1073/pnas.012025199 10.1261/rna.810208 10.1371/journal.pone.0046665 10.1016/S1476-5586(04)80047-2 10.1016/j.devcel.2005.02.009 10.1038/nature11003 10.1038/onc.2010.225 10.1038/5007 10.4161/cbt.11.1.13965 10.1038/onc.2010.264 10.1016/S0092-8674(00)80919-8 10.1051/jbio/2004198040375 10.1038/onc.2013.140 10.1038/onc.2011.562 10.1016/j.cellsig.2013.03.025 10.1016/j.ceb.2005.08.002 10.1046/j.1432-1033.2002.02921.x 10.1517/14712598.2011.542749 10.1083/jcb.201105103 10.4161/rna.8.5.16154 10.1016/j.devcel.2004.12.004 10.1152/ajpgi.00008.2006 10.1126/science.1152623 10.1016/j.ccr.2010.09.005 10.1007/s10555-014-9497-1 10.1093/nass/nrm208 |
ContentType | Journal Article |
Copyright | The Author(s) 2016 COPYRIGHT 2016 Nature Publishing Group Copyright Nature Publishing Group Jun 16, 2016 Copyright © 2016 Macmillan Publishers Limited 2016 Macmillan Publishers Limited |
Copyright_xml | – notice: The Author(s) 2016 – notice: COPYRIGHT 2016 Nature Publishing Group – notice: Copyright Nature Publishing Group Jun 16, 2016 – notice: Copyright © 2016 Macmillan Publishers Limited 2016 Macmillan Publishers Limited |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PQEST PQQKQ PQUKI PRINS Q9U RC3 7X8 5PM |
DOI | 10.1038/onc.2015.365 |
DatabaseName | SpringerOpen Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Research Library Prep MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology |
DocumentTitleAlternate | Sprouty and colorectal cancer |
EISSN | 1476-5594 |
EndPage | 3162 |
ExternalDocumentID | 4090562831 A456758531 10_1038_onc_2015_365 26434583 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural Feature |
GrantInformation_xml | – fundername: Intramural VA grantid: VA999999 – fundername: NCI NIH HHS grantid: R03 CA150081 – fundername: BLRD VA grantid: I01 BX000824 – fundername: NIDCD NIH HHS grantid: R01 DC010387 |
GroupedDBID | --- -Q- 0R~ 123 29N 2WC 36B 39C 3V. 4.4 406 53G 5RE 70F 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AACDK AANZL AASML AATNV AAWBL AAZLF ABAKF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGEZK AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN AZQEC BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI C6C CCPQU CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAP EBLON EBS EE. EIOEI EJD ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ITC IWAJR JSO JZLTJ KQ8 L7B LK8 M0L M1P M2O M7P N9A NAO NQJWS NXXTH O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SNX SNYQT SOHCF SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TSG UKHRP W2D WH7 AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION AADWK AAYFA AAYJO ABGIJ ACBMV ACBRV ACBYP ACIGE ACTTH ACVWB ADMDM ADQMX ADYYL AEDAW AEFTE AFNRJ AGGBP AJCLW AJDOV AMRJV NYICJ ZA5 7TM 7TO 7U9 7XB 8FD 8FK FR3 H94 K9. MBDVC P64 PQEST PQUKI PRINS Q9U RC3 7X8 5PM ABAWZ ABDBF B0M EAD EBC EBD EMB EMK EMOBN EPL FRP SV3 TUS ~8M |
ID | FETCH-LOGICAL-c616t-df23ed02b5bebdbaddb8e5fc4b43e81131849fa9a8335c6dd5970760da96d9203 |
IEDL.DBID | BENPR |
ISSN | 0950-9232 |
IngestDate | Tue Sep 17 21:25:14 EDT 2024 Fri Aug 16 05:15:20 EDT 2024 Fri Aug 16 06:17:28 EDT 2024 Thu Oct 10 18:18:06 EDT 2024 Thu Feb 22 23:44:20 EST 2024 Fri Feb 02 04:26:09 EST 2024 Fri Aug 23 01:51:19 EDT 2024 Wed Oct 16 00:59:26 EDT 2024 Fri Oct 11 20:46:55 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 24 |
Language | English |
License | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c616t-df23ed02b5bebdbaddb8e5fc4b43e81131849fa9a8335c6dd5970760da96d9203 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1038/onc.2015.365 |
PMID | 26434583 |
PQID | 1797270214 |
PQPubID | 36330 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4850112 proquest_miscellaneous_1808715403 proquest_miscellaneous_1797866686 proquest_journals_1797270214 gale_infotracmisc_A456758531 gale_infotracacademiconefile_A456758531 crossref_primary_10_1038_onc_2015_365 pubmed_primary_26434583 springer_journals_10_1038_onc_2015_365 |
PublicationCentury | 2000 |
PublicationDate | 2016-06-16 |
PublicationDateYYYYMMDD | 2016-06-16 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-16 day: 16 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England – name: New York |
PublicationTitle | Oncogene |
PublicationTitleAbbrev | Oncogene |
PublicationTitleAlternate | Oncogene |
PublicationYear | 2016 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Shim, Minowada, Coling, Martin (CR38) 2005; 8 Cheng, Chan, Wang, Zhang, Sun, Wang (CR31) 2007; 67 Feng, Wu, Tsao, Chang, Lu, Yeh (CR7) 2011; 11 Yamaguchi, Wyckoff, Condeelis (CR11) 2005; 17 Buchan, Parker (CR17) 2007; 318 Natalwala, Spychal, Tselepis (CR13) 2008; 14 Li, Zhou, Rowe, Hu, Schlaepfer, Ilic (CR21) 2011; 195 Hick, Delmarcelle, Bouquet, Klotz, Copetti, Forez (CR34) 2013; 381 Acunzo, Romano, Palmieri, Lagana, Garofalo, Balatti (CR36) 2013; 110 Rhodes, Yu, Shanker, Deshpande, Varambally, Ghosh (CR8) 2004; 6 Holgren, Dougherty, Edwin, Cerasi, Taylor, Fichera (CR5) 2010; 29 Hacohen, Kramer, Sutherland, Hiromi, Krasnow (CR1) 1998; 92 Leeksma, Van Achterberg, Tsumura, Toshima, Eldering, Kroes (CR2) 2002; 269 Ordonez-Moran, Irmisch, Barbachano, Chicote, Tenbaum, Landolfi (CR6) 2014; 33 Watanabe, Kobunai, Yamamoto, Matsuda, Ishihara, Nozawa (CR10) 2011; 47 Puisieux, Brabletz, Caramel (CR12) 2014; 16 Zhao, Ren, Wang, Sun, Yu, Wang (CR18) 2014; 4 Barbachano, Ordonez-Moran, Garcia, Sanchez, Pereira, Larriba (CR9) 2010; 29 Hino, Tsuchiya, Fukao, Kiga, Okamoto, Kanai (CR25) 2008; 14 Kroepil, Fluegen, Totikov, Baldus, Vay, Schauer (CR28) 2012; 7 Barretina, Caponigro, Stransky, Venkatesan, Margolin, Kim (CR35) 2012; 483 Su, Cooke, Ching, Hakak, Walker, Wiltshire (CR3) 2002; 99 Diaz-Lopez, Moreno-Bueno, Cano (CR14) 2014; 6 Lu, Getz, Miska, Alvarez-Saavedra, Lamb, Peck (CR22) 2005; 435 Chi, Itaranta, Zhang, Vainio (CR33) 2006; 147 Barad, Meiri, Avniel, Aharonov, Barzilai, Bentwich (CR23) 2004; 14 Kumarswamy, Volkmann, Thum (CR15) 2011; 8 CR26 Tsanou, Peschos, Batistatou, Charalabopoulos, Charalabopoulos (CR29) 2008; 28 Rychahou, Kang, Gulhati, Doan, Chen, Xiao (CR32) 2008; 105 Tazawa, Kagawa, Fujiwara (CR16) 2011; 11 Khare, Holgren, Samarel (CR41) 2006; 291 Khare, Bissonnette, Wali, Skarosi, Boss, von Lintig (CR42) 1999; 276 Villagrasa, Diaz, Vinas-Castells, Peiro, Del Valle-Perez, Dave (CR19) 2012; 31 Chiang, Song, Wang, Liu, Gao, Liang (CR24) 2012; 3 Soriano (CR39) 1999; 21 Hayashi, McMahon (CR40) 2002; 244 Masoumi-Moghaddam, Amini, Morris (CR4) 2014; 33 Basson, Akbulut, Watson-Johnson, Simon, Carroll, Shakya (CR37) 2005; 8 Agarwal, Brattain, Chowdhury (CR20) 2013; 25 Pichiorri, Suh, Rocci, De Luca, Taccioli, Santhanam (CR27) 2010; 18 Grille, Bellacosa, Larue (CR30) 2004; 198 25285168 - Theranostics. 2014 Sep 19;4(12):1193-208 16675530 - Endocrinology. 2006 Aug;147(8):3777-88 19189669 - Anticancer Res. 2008 Nov-Dec;28(6A):3815-26 15068665 - Neoplasia. 2004 Jan-Feb;6(1):1-6 23603750 - Cell Signal. 2013 Aug;25(8):1711-9 15691764 - Dev Cell. 2005 Feb;8(2):229-39 20661223 - Oncogene. 2010 Sep 23;29(38):5241-53 16920701 - Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G1100-12 12027893 - Eur J Biochem. 2002 May;269(10):2546-56 9458049 - Cell. 1998 Jan 23;92(2):253-63 11944939 - Dev Biol. 2002 Apr 15;244(2):305-18 16098726 - Curr Opin Cell Biol. 2005 Oct;17(5):559-64 28288131 - Oncogene. 2017 Jul 13;36(28):4088 24744103 - Cancer Metastasis Rev. 2014 Sep;33(2-3):695-720 23624922 - Oncogene. 2014 Apr 10;33(15):1975-85 22158034 - Oncogene. 2012 Sep 6;31(36):4022-33 22969930 - Exp Ther Med. 2012 Mar;3(3):560-566 15944708 - Nature. 2005 Jun 9;435(7043):834-8 11904358 - Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4465-70 18492795 - RNA. 2008 Jul;14(7):1433-42 21099344 - Cancer Biol Ther. 2011 Jan 1;11(1):111-21 22105351 - J Cell Biol. 2011 Nov 28;195(5):729-38 20543868 - Oncogene. 2010 Aug 26;29(34):4800-13 19075230 - Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20315-20 24812525 - Cancer Manag Res. 2014 Apr 25;6:205-16 23029563 - PLoS One. 2012;7(9):e46665 21712654 - RNA Biol. 2011 Sep-Oct;8(5):706-13 21531130 - Eur J Cancer. 2011 Sep;47(13):1946-54 18609701 - World J Gastroenterol. 2008 Jun 28;14(24):3792-7 18096794 - Science. 2007 Dec 21;318(5858):1877-8 18029763 - Nucleic Acids Symp Ser (Oxf). 2007;(51):415-6 23650389 - Proc Natl Acad Sci U S A. 2013 May 21;110(21):8573-8 21219233 - Expert Opin Biol Ther. 2011 Feb;11(2):145-55 15969343 - J Soc Biol. 2004;198(4):375-8 23707896 - Dev Biol. 2013 Sep 1;381(1):227-40 9916792 - Nat Genet. 1999 Jan;21(1):70-1 10198345 - Am J Physiol. 1999 Apr;276(4 Pt 1):G1005-15 22460905 - Nature. 2012 Mar 28;483(7391):603-7 15574827 - Genome Res. 2004 Dec;14(12):2486-94 15809037 - Dev Cell. 2005 Apr;8(4):553-64 17332325 - Cancer Res. 2007 Mar 1;67(5):1979-87 24875735 - Nat Cell Biol. 2014 Jun;16(6):488-94 20951946 - Cancer Cell. 2010 Oct 19;18(4):367-81 H Yamaguchi (BFonc2015365_CR11) 2005; 17 S Masoumi-Moghaddam (BFonc2015365_CR4) 2014; 33 R Kumarswamy (BFonc2015365_CR15) 2011; 8 S Khare (BFonc2015365_CR41) 2006; 291 H Tazawa (BFonc2015365_CR16) 2011; 11 HJ Zhao (BFonc2015365_CR18) 2014; 4 F Kroepil (BFonc2015365_CR28) 2012; 7 M Acunzo (BFonc2015365_CR36) 2013; 110 T Watanabe (BFonc2015365_CR10) 2011; 47 A Puisieux (BFonc2015365_CR12) 2014; 16 L Chi (BFonc2015365_CR33) 2006; 147 GZ Cheng (BFonc2015365_CR31) 2007; 67 K Shim (BFonc2015365_CR38) 2005; 8 PG Rychahou (BFonc2015365_CR32) 2008; 105 J Barretina (BFonc2015365_CR35) 2012; 483 E Tsanou (BFonc2015365_CR29) 2008; 28 P Ordonez-Moran (BFonc2015365_CR6) 2014; 33 P Villagrasa (BFonc2015365_CR19) 2012; 31 A Natalwala (BFonc2015365_CR13) 2008; 14 E Agarwal (BFonc2015365_CR20) 2013; 25 C Holgren (BFonc2015365_CR5) 2010; 29 A Barbachano (BFonc2015365_CR9) 2010; 29 AI Su (BFonc2015365_CR3) 2002; 99 N Hacohen (BFonc2015365_CR1) 1998; 92 BFonc2015365_CR26 P Soriano (BFonc2015365_CR39) 1999; 21 O Barad (BFonc2015365_CR23) 2004; 14 A Diaz-Lopez (BFonc2015365_CR14) 2014; 6 K Hino (BFonc2015365_CR25) 2008; 14 J Lu (BFonc2015365_CR22) 2005; 435 F Pichiorri (BFonc2015365_CR27) 2010; 18 XY Li (BFonc2015365_CR21) 2011; 195 DR Rhodes (BFonc2015365_CR8) 2004; 6 OC Leeksma (BFonc2015365_CR2) 2002; 269 S Hayashi (BFonc2015365_CR40) 2002; 244 S Khare (BFonc2015365_CR42) 1999; 276 MA Basson (BFonc2015365_CR37) 2005; 8 YH Feng (BFonc2015365_CR7) 2011; 11 AC Hick (BFonc2015365_CR34) 2013; 381 JR Buchan (BFonc2015365_CR17) 2007; 318 Y Chiang (BFonc2015365_CR24) 2012; 3 S Grille (BFonc2015365_CR30) 2004; 198 |
References_xml | – volume: 47 start-page: 1946 year: 2011 end-page: 1954 ident: CR10 article-title: Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways publication-title: Eur J Cancer doi: 10.1016/j.ejca.2011.03.029 contributor: fullname: Nozawa – volume: 16 start-page: 488 year: 2014 end-page: 494 ident: CR12 article-title: Oncogenic roles of EMT-inducing transcription factors publication-title: Nat Cell Biol doi: 10.1038/ncb2976 contributor: fullname: Caramel – volume: 3 start-page: 560 year: 2012 end-page: 566 ident: CR24 article-title: microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer publication-title: Exp Ther Med doi: 10.3892/etm.2011.436 contributor: fullname: Liang – volume: 105 start-page: 20315 year: 2008 end-page: 20320 ident: CR32 article-title: Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0810715105 contributor: fullname: Xiao – volume: 110 start-page: 8573 year: 2013 end-page: 8578 ident: CR36 article-title: Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1302107110 contributor: fullname: Balatti – volume: 67 start-page: 1979 year: 2007 end-page: 1987 ident: CR31 article-title: Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-1479 contributor: fullname: Wang – volume: 381 start-page: 227 year: 2013 end-page: 240 ident: CR34 article-title: Reciprocal epithelial:endothelial paracrine interactions during thyroid development govern follicular organization and C-cells differentiation publication-title: Dev Biol doi: 10.1016/j.ydbio.2013.04.022 contributor: fullname: Forez – volume: 244 start-page: 305 year: 2002 end-page: 318 ident: CR40 article-title: Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse publication-title: Dev Biol doi: 10.1006/dbio.2002.0597 contributor: fullname: McMahon – volume: 4 start-page: 1193 year: 2014 end-page: 1208 ident: CR18 article-title: MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway publication-title: Theranostics doi: 10.7150/thno.8712 contributor: fullname: Wang – volume: 435 start-page: 834 year: 2005 end-page: 838 ident: CR22 article-title: MicroRNA expression profiles classify human cancers publication-title: Nature doi: 10.1038/nature03702 contributor: fullname: Peck – volume: 14 start-page: 2486 year: 2004 end-page: 2494 ident: CR23 article-title: MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues publication-title: Genome Res doi: 10.1101/gr.2845604 contributor: fullname: Bentwich – volume: 14 start-page: 3792 year: 2008 end-page: 3797 ident: CR13 article-title: Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract publication-title: World J Gastroenterol doi: 10.3748/wjg.14.3792 contributor: fullname: Tselepis – volume: 147 start-page: 3777 year: 2006 end-page: 3788 ident: CR33 article-title: Sprouty2 is involved in male sex organogenesis by controlling fibroblast growth factor 9-induced mesonephric cell migration to the developing testis publication-title: Endocrinology doi: 10.1210/en.2006-0299 contributor: fullname: Vainio – volume: 99 start-page: 4465 year: 2002 end-page: 4470 ident: CR3 article-title: Large-scale analysis of the human and mouse transcriptomes publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.012025199 contributor: fullname: Wiltshire – volume: 14 start-page: 1433 year: 2008 end-page: 1442 ident: CR25 article-title: Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation publication-title: RNA doi: 10.1261/rna.810208 contributor: fullname: Kanai – volume: 7 start-page: e46665 year: 2012 ident: CR28 article-title: Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas publication-title: PLoS One doi: 10.1371/journal.pone.0046665 contributor: fullname: Schauer – volume: 6 start-page: 1 year: 2004 end-page: 6 ident: CR8 article-title: ONCOMINE: a cancer microarray database and integrated data-mining platform publication-title: Neoplasia doi: 10.1016/S1476-5586(04)80047-2 contributor: fullname: Ghosh – volume: 8 start-page: 553 year: 2005 end-page: 564 ident: CR38 article-title: Sprouty2, a mouse deafness gene, regulates cell fate decisions in the auditory sensory epithelium by antagonizing FGF signaling publication-title: Dev Cell doi: 10.1016/j.devcel.2005.02.009 contributor: fullname: Martin – volume: 483 start-page: 603 year: 2012 end-page: 607 ident: CR35 article-title: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity publication-title: Nature doi: 10.1038/nature11003 contributor: fullname: Kim – volume: 29 start-page: 4800 year: 2010 end-page: 4813 ident: CR9 article-title: SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity publication-title: Oncogene doi: 10.1038/onc.2010.225 contributor: fullname: Larriba – volume: 6 start-page: 205 year: 2014 end-page: 216 ident: CR14 article-title: Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives publication-title: Cancer Manag Res contributor: fullname: Cano – volume: 21 start-page: 70 year: 1999 end-page: 71 ident: CR39 article-title: Generalized lacZ expression with the ROSA26 Cre reporter strain publication-title: Nat Genet doi: 10.1038/5007 contributor: fullname: Soriano – volume: 11 start-page: 111 year: 2011 end-page: 121 ident: CR7 article-title: Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: correlation with the clinical stage of the disease publication-title: Cancer Biol Ther doi: 10.4161/cbt.11.1.13965 contributor: fullname: Yeh – volume: 29 start-page: 5241 year: 2010 end-page: 5253 ident: CR5 article-title: Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas publication-title: Oncogene doi: 10.1038/onc.2010.264 contributor: fullname: Fichera – volume: 92 start-page: 253 year: 1998 end-page: 263 ident: CR1 article-title: sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways publication-title: Cell doi: 10.1016/S0092-8674(00)80919-8 contributor: fullname: Krasnow – volume: 28 start-page: 3815 year: 2008 end-page: 3826 ident: CR29 article-title: The E-cadherin adhesion molecule and colorectal cancer. A global literature approach publication-title: Anticancer Res contributor: fullname: Charalabopoulos – volume: 198 start-page: 375 year: 2004 end-page: 378 ident: CR30 article-title: [Regulation of E-cadherin by the Akt protein kinase B] publication-title: J Soc Biol doi: 10.1051/jbio/2004198040375 contributor: fullname: Larue – volume: 33 start-page: 1975 year: 2014 end-page: 1985 ident: CR6 article-title: SPROUTY2 is a beta-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer publication-title: Oncogene doi: 10.1038/onc.2013.140 contributor: fullname: Landolfi – volume: 31 start-page: 4022 year: 2012 end-page: 4033 ident: CR19 article-title: Akt2 interacts with Snail1 in the E-cadherin promoter publication-title: Oncogene doi: 10.1038/onc.2011.562 contributor: fullname: Dave – volume: 25 start-page: 1711 year: 2013 end-page: 1719 ident: CR20 article-title: Cell survival and metastasis regulation by Akt signaling in colorectal cancer publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.03.025 contributor: fullname: Chowdhury – volume: 17 start-page: 559 year: 2005 end-page: 564 ident: CR11 article-title: Cell migration in tumors publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2005.08.002 contributor: fullname: Condeelis – volume: 276 start-page: G1005 year: 1999 end-page: G1015 ident: CR42 article-title: 1,25-dihydroxyvitamin D3 but not TPA activates PLD in Caco-2 cells via pp60(c-src) and RhoA publication-title: Am J Physiol contributor: fullname: von Lintig – volume: 269 start-page: 2546 year: 2002 end-page: 2556 ident: CR2 article-title: Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1 publication-title: Eur J Biochem doi: 10.1046/j.1432-1033.2002.02921.x contributor: fullname: Kroes – volume: 11 start-page: 145 year: 2011 end-page: 155 ident: CR16 article-title: MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors publication-title: Expert Opin Biol Ther doi: 10.1517/14712598.2011.542749 contributor: fullname: Fujiwara – volume: 195 start-page: 729 year: 2011 end-page: 738 ident: CR21 article-title: Snail1 controls epithelial-mesenchymal lineage commitment in focal adhesion kinase-null embryonic cells publication-title: J Cell Biol doi: 10.1083/jcb.201105103 contributor: fullname: Ilic – volume: 8 start-page: 706 year: 2011 end-page: 713 ident: CR15 article-title: Regulation and function of miRNA-21 in health and disease publication-title: RNA Biol doi: 10.4161/rna.8.5.16154 contributor: fullname: Thum – ident: CR26 – volume: 8 start-page: 229 year: 2005 end-page: 239 ident: CR37 article-title: Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction publication-title: Dev Cell doi: 10.1016/j.devcel.2004.12.004 contributor: fullname: Shakya – volume: 291 start-page: G1100 year: 2006 end-page: G1112 ident: CR41 article-title: Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00008.2006 contributor: fullname: Samarel – volume: 318 start-page: 1877 year: 2007 end-page: 1878 ident: CR17 article-title: Molecular biology. The two faces of miRNA publication-title: Science doi: 10.1126/science.1152623 contributor: fullname: Parker – volume: 18 start-page: 367 year: 2010 end-page: 381 ident: CR27 article-title: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.09.005 contributor: fullname: Santhanam – volume: 33 start-page: 695 year: 2014 end-page: 720 ident: CR4 article-title: The developing story of Sprouty and cancer publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-014-9497-1 contributor: fullname: Morris – volume: 147 start-page: 3777 year: 2006 ident: BFonc2015365_CR33 publication-title: Endocrinology doi: 10.1210/en.2006-0299 contributor: fullname: L Chi – volume: 291 start-page: G1100 year: 2006 ident: BFonc2015365_CR41 publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00008.2006 contributor: fullname: S Khare – volume: 16 start-page: 488 year: 2014 ident: BFonc2015365_CR12 publication-title: Nat Cell Biol doi: 10.1038/ncb2976 contributor: fullname: A Puisieux – volume: 110 start-page: 8573 year: 2013 ident: BFonc2015365_CR36 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1302107110 contributor: fullname: M Acunzo – volume: 31 start-page: 4022 year: 2012 ident: BFonc2015365_CR19 publication-title: Oncogene doi: 10.1038/onc.2011.562 contributor: fullname: P Villagrasa – volume: 11 start-page: 111 year: 2011 ident: BFonc2015365_CR7 publication-title: Cancer Biol Ther doi: 10.4161/cbt.11.1.13965 contributor: fullname: YH Feng – volume: 47 start-page: 1946 year: 2011 ident: BFonc2015365_CR10 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2011.03.029 contributor: fullname: T Watanabe – volume: 483 start-page: 603 year: 2012 ident: BFonc2015365_CR35 publication-title: Nature doi: 10.1038/nature11003 contributor: fullname: J Barretina – volume: 381 start-page: 227 year: 2013 ident: BFonc2015365_CR34 publication-title: Dev Biol doi: 10.1016/j.ydbio.2013.04.022 contributor: fullname: AC Hick – volume: 6 start-page: 205 year: 2014 ident: BFonc2015365_CR14 publication-title: Cancer Manag Res contributor: fullname: A Diaz-Lopez – volume: 6 start-page: 1 year: 2004 ident: BFonc2015365_CR8 publication-title: Neoplasia doi: 10.1016/S1476-5586(04)80047-2 contributor: fullname: DR Rhodes – volume: 8 start-page: 553 year: 2005 ident: BFonc2015365_CR38 publication-title: Dev Cell doi: 10.1016/j.devcel.2005.02.009 contributor: fullname: K Shim – volume: 14 start-page: 2486 year: 2004 ident: BFonc2015365_CR23 publication-title: Genome Res doi: 10.1101/gr.2845604 contributor: fullname: O Barad – volume: 28 start-page: 3815 year: 2008 ident: BFonc2015365_CR29 publication-title: Anticancer Res contributor: fullname: E Tsanou – volume: 105 start-page: 20315 year: 2008 ident: BFonc2015365_CR32 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0810715105 contributor: fullname: PG Rychahou – volume: 4 start-page: 1193 year: 2014 ident: BFonc2015365_CR18 publication-title: Theranostics doi: 10.7150/thno.8712 contributor: fullname: HJ Zhao – volume: 244 start-page: 305 year: 2002 ident: BFonc2015365_CR40 publication-title: Dev Biol doi: 10.1006/dbio.2002.0597 contributor: fullname: S Hayashi – volume: 33 start-page: 1975 year: 2014 ident: BFonc2015365_CR6 publication-title: Oncogene doi: 10.1038/onc.2013.140 contributor: fullname: P Ordonez-Moran – volume: 29 start-page: 5241 year: 2010 ident: BFonc2015365_CR5 publication-title: Oncogene doi: 10.1038/onc.2010.264 contributor: fullname: C Holgren – volume: 33 start-page: 695 year: 2014 ident: BFonc2015365_CR4 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-014-9497-1 contributor: fullname: S Masoumi-Moghaddam – volume: 17 start-page: 559 year: 2005 ident: BFonc2015365_CR11 publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2005.08.002 contributor: fullname: H Yamaguchi – volume: 11 start-page: 145 year: 2011 ident: BFonc2015365_CR16 publication-title: Expert Opin Biol Ther doi: 10.1517/14712598.2011.542749 contributor: fullname: H Tazawa – volume: 25 start-page: 1711 year: 2013 ident: BFonc2015365_CR20 publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.03.025 contributor: fullname: E Agarwal – volume: 99 start-page: 4465 year: 2002 ident: BFonc2015365_CR3 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.012025199 contributor: fullname: AI Su – volume: 21 start-page: 70 year: 1999 ident: BFonc2015365_CR39 publication-title: Nat Genet doi: 10.1038/5007 contributor: fullname: P Soriano – volume: 276 start-page: G1005 year: 1999 ident: BFonc2015365_CR42 publication-title: Am J Physiol contributor: fullname: S Khare – volume: 8 start-page: 229 year: 2005 ident: BFonc2015365_CR37 publication-title: Dev Cell doi: 10.1016/j.devcel.2004.12.004 contributor: fullname: MA Basson – volume: 14 start-page: 3792 year: 2008 ident: BFonc2015365_CR13 publication-title: World J Gastroenterol doi: 10.3748/wjg.14.3792 contributor: fullname: A Natalwala – volume: 435 start-page: 834 year: 2005 ident: BFonc2015365_CR22 publication-title: Nature doi: 10.1038/nature03702 contributor: fullname: J Lu – volume: 8 start-page: 706 year: 2011 ident: BFonc2015365_CR15 publication-title: RNA Biol doi: 10.4161/rna.8.5.16154 contributor: fullname: R Kumarswamy – volume: 3 start-page: 560 year: 2012 ident: BFonc2015365_CR24 publication-title: Exp Ther Med doi: 10.3892/etm.2011.436 contributor: fullname: Y Chiang – volume: 269 start-page: 2546 year: 2002 ident: BFonc2015365_CR2 publication-title: Eur J Biochem doi: 10.1046/j.1432-1033.2002.02921.x contributor: fullname: OC Leeksma – ident: BFonc2015365_CR26 doi: 10.1093/nass/nrm208 – volume: 14 start-page: 1433 year: 2008 ident: BFonc2015365_CR25 publication-title: RNA doi: 10.1261/rna.810208 contributor: fullname: K Hino – volume: 318 start-page: 1877 year: 2007 ident: BFonc2015365_CR17 publication-title: Science doi: 10.1126/science.1152623 contributor: fullname: JR Buchan – volume: 195 start-page: 729 year: 2011 ident: BFonc2015365_CR21 publication-title: J Cell Biol doi: 10.1083/jcb.201105103 contributor: fullname: XY Li – volume: 18 start-page: 367 year: 2010 ident: BFonc2015365_CR27 publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.09.005 contributor: fullname: F Pichiorri – volume: 92 start-page: 253 year: 1998 ident: BFonc2015365_CR1 publication-title: Cell doi: 10.1016/S0092-8674(00)80919-8 contributor: fullname: N Hacohen – volume: 29 start-page: 4800 year: 2010 ident: BFonc2015365_CR9 publication-title: Oncogene doi: 10.1038/onc.2010.225 contributor: fullname: A Barbachano – volume: 198 start-page: 375 year: 2004 ident: BFonc2015365_CR30 publication-title: J Soc Biol doi: 10.1051/jbio/2004198040375 contributor: fullname: S Grille – volume: 67 start-page: 1979 year: 2007 ident: BFonc2015365_CR31 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-1479 contributor: fullname: GZ Cheng – volume: 7 start-page: e46665 year: 2012 ident: BFonc2015365_CR28 publication-title: PLoS One doi: 10.1371/journal.pone.0046665 contributor: fullname: F Kroepil |
SSID | ssj0007902 |
Score | 2.411811 |
Snippet | Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC)... Abstract Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal... |
SourceID | pubmedcentral proquest gale crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3151 |
SubjectTerms | 631/67 Adaptor Proteins, Signal Transducing - genetics Adaptor Proteins, Signal Transducing - metabolism Animals Apoptosis Biomarkers Cadherins - biosynthesis Cadherins - metabolism Cell Biology Cellular biology Colorectal cancer Colorectal Neoplasms - genetics Colorectal Neoplasms - metabolism Colorectal Neoplasms - pathology Development and progression Epithelial-Mesenchymal Transition Female Genetic aspects Genetic regulation Health aspects Human Genetics Humans Internal Medicine Intracellular Signaling Peptides and Proteins - genetics Intracellular Signaling Peptides and Proteins - metabolism Medicine Medicine & Public Health Membrane Proteins - genetics Membrane Proteins - metabolism Membranes Mice Oncology Original original-article Phosphoproteins - genetics Phosphoproteins - metabolism Plasma Proto-Oncogene Proteins c-akt - blood Proto-Oncogene Proteins c-akt - metabolism Transfection Tumor suppressor genes Up-Regulation |
SummonAdditionalLinks | – databaseName: SpringerOpen dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Li9RAEC7WFR8X0dHV7K4SYdVT3CT9SOJtGFwWQU8u7K3pV5gBNxlmM4e5-R_8h_4Sq_JiM4h4CYGqzqOruvor6tEAZ0a7wsQli7TNYnRQMhmZLHWRYIidvdROlm2C7Dd5ecW_XIvrAzgbamEm8XuWn9cV9RlMxEcmxT24LxIZk-4u5GK0t1mXWYhYIY4QrqR9evv-6MnGs29-7-w_-7mRewHSdt-5eApPesAYzjsJP4MDX83gQXeE5G4GjxbDiW0zePi1D5Q_h2re7NY0_yGlD4Z1GeLz622zC1dVSI2qydAh1ZLQN59G6mZIjK2Qcbkyq-Y29Guq2_iBivr7568bqlayy90NDm5on2tTvl7A1cXn74vLqD9aIbIykU3kypR5F6dGGG8cCsyZ3IvScsOZz5MEVzovSl1oqsmy0jn0OyiG53QhXZHG7AgOq7ryryDMrMbhaeq9L7gu8MIZ19YUJWI5UZgA3g3zrtZdBw3VRr5ZrlA-iuSjUD4BfCChKFpY-P1W9_UB-BZqUaXmCPXIuWFJAKcTTpxlOyUPYlX9grxVaHcyKr1LeABvRzKNpCSzytfbjidHdy6X_-DJY3QxEeayAF52mjL-FWJLRmHoALKJDo0M1Mp7SqlWy7alN88FGto0gPeDtt359L9M1vH_Mp7AY7yVlNyWyFM4bDZb_xphVGPetKvoD2pAHD4 priority: 102 providerName: Springer Nature |
Title | Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition |
URI | https://link.springer.com/article/10.1038/onc.2015.365 https://www.ncbi.nlm.nih.gov/pubmed/26434583 https://www.proquest.com/docview/1797270214 https://search.proquest.com/docview/1797866686 https://search.proquest.com/docview/1808715403 https://pubmed.ncbi.nlm.nih.gov/PMC4850112 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbptAcNQkatNL1bptQptGVOrjRAMsLNBL5KJEUaVGVdVIvqF9IVtKwLHxwX_fGViobUW5IKGZtWFndh7MC-CTFDqTfsk8oRIfHZSEezIJtRcztJ0NF5qXbYLsNb-6iX5O4on94La0aZW9TGwFta4VfSM_Q8ZJqHYqiM7n9x5NjaLoqh2hsQcHCKAw7cGPi-vffwZZnHRZh2hH-B6aMqFNffdZelZX1MEwiL8xUiwbSmlXNG_opt28yZ3gaauTLl_CC2tMuuOO-q_gialG8LQbL7kewWHeT3MbwbNfNoj-Gm7HzXpOtHEptdCtSxd_v141a3dWudTEmoQgQhUxxOL7AF30SbMVIk5nctYsXTOnmo5bZGLvjuqY1HR9h0sb0oBtMtgbuLm8-JtfeXbogqd4wBtPlyEz2g9lLI3USEotUxOXKpIRM2kQoAyIslJkgqq1FNcaPRKK7mmRcZ2FPnsL-1VdmWNwEyVweRgaY7JIZHiJWCSUzEq08uJMOvC53_Vi3vXWKNqYOEsLpE5B1CmQOg58JZIUdOTw-ZWwlQP4L9S8qhijEUhuDwscONnCxD1W2-CeqIU9qsviP2M58HEA00pKP6tMvepwUnT0Uv4ITuqj84kGMHPgqOOT4a3Q6mQUoHYg2eKgAYGafG9Dqtm0bfYdpTGK4NCBLz2vbTz6A5v17vF3fA_PEZNTslvAT2C_WazMBzSrGnkKe8kkwWuaB6f2HOFdzvN_5vInVg |
link.rule.ids | 230,315,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,41153,42222,43343,43612,43838,51609,74100,74369,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9swDCa2Dlt3Kbrs5bXdPGCPk1fbkmV7lyEIVmRb21ML9CboZSRAa2eJc8i_H-lHmgRDL76Q8kOkSMr8SAF80srmOixYoEwa4gYlFYFOYxskDGNnJ5QVRQOQvRTja_77JrnpfrgtOlhlbxMbQ20rQ__IT1FxUqqdiviP2d-ATo2i7Gp3hMZjeMIZ-mqqFB_dQzzSFnOIUUQYYCATd8D3kGWnVUn9C6PkGyO3suGSdg3zhmfaRU3upE4bj3R2CAddKOkPW9m_gEeuHMDT9nDJ1QD2R_1ZbgN4dtGl0F_C7bBezUgyPgEL_arw8f7Vsl7509KnFtZkApFqSB3m39fUeQ-ZLZFxMtXTeuG7GVV03KIKB3dUxWQmqzscWpP_a6Bgr-D67OfVaBx0Ry4ERkSiDmwRM2fDWCfaaYuCtDpzSWG45sxlUYQWgOeFyhXVahlhLe5HKLdnVS5sHofsNeyVVenegp8ahcPj2DmXc5XjhTOujM4LjPGSXHvwuZ91OWs7a8gmI84yidKRJB2J0vHgK4lE0oLD9zeqqxvAp1DrKjnEEJA2PSzy4HiLE-fYbJN7ocpuoS7kvVp58HFNppEEPitdtWx5MtzmZeIBnizErSeGv8yDN62erL8KY05G6WkP0i0NWjNQi-9tSjmdNK2-eZagAY49-NLr2sar_2ey3j38jR9gf3x1cS7Pf13-OYLnOEoQ7C0Sx7BXz5fuBAOsWr9vVtE_5YkmFw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEB5BEaUXBOFlKGAkHic3ttde21xQFIjKq-JApd5W-7ISqbXTxDnk3zNjr9MkQr3kMruJvTM7j8w3MwDvlTSFCksWSJ2FGKBkPFBZbIKUoe9suTS8bAGyZ_z0PPlxkV44_NPSwSp7ndgqalNr-o98iIKTUe1UlAxLB4v483XyZX4d0AQpyrS6cRp34R5aRU4Sno9v4B5Zhz9EjyIM0KmJHQg-ZPmwrqiXYZSeMDIxW-ZpX0lvWal9BOVeGrW1TpNH8NC5lf6ok4PHcMdWA7jfDZpcD-DBuJ_rNoDD3y6d_gQuR816TlzyCWTo16WP31-vmrU_q3xqZ03qEKmaRGPxeUNd9PDZChdOZ2rWLH07p-qOSxTn4IoqmvR0fYVbG7KFLSzsKZxPvv0dnwZu_EKgecSbwJQxsyaMVaqsMshUo3KbljpRCbN5FKE2SIpSFpLqtjQ3BmMTyvMZWXBTxCF7BgdVXdkX4Gda4vY4ttYWiSzwI2GJ1Koo0d9LC-XBh_7UxbzrsiHa7DjLBXJHEHcEcseDT8QSQZcPn19LV0OAv0JtrMQI3UEKgFjkwfHOSjxjvUvumSrcpV2KGxHz4N2GTDsJiFbZetWtyTHky_kta_IQw1B0hZkHzzs52bwV-p-MUtUeZDsStFlA7b53KdVs2rb9TvIUlXHswcde1rYe_T-H9fL2d3wLh3iBxK_vZz9fwRFu4oSAi_gxHDSLlX2Nvlaj3rSX6B_HqCpV |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Atypical+role+of+sprouty+in+colorectal+cancer%3A+sprouty+repression+inhibits+epithelial-mesenchymal+transition&rft.jtitle=Oncogene&rft.au=Zhang%2C+Q&rft.au=Wei%2C+T&rft.au=Shim%2C+K&rft.au=Wright%2C+K&rft.date=2016-06-16&rft.eissn=1476-5594&rft.volume=35&rft.issue=24&rft.spage=3151&rft_id=info:doi/10.1038%2Fonc.2015.365&rft_id=info%3Apmid%2F26434583&rft.externalDocID=26434583 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |